APO LMV 150 Pill: white, four-sided, 14mm
The pill with imprint APO LMV 150 (White, Four-sided, 14mm) has been identified as Lamivudine 150 mg and is used for Hepatitis B, Nonoccupational Exposure, Occupational Exposure, and HIV Infection. It belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is not a controlled substance.
Images for APO LMV 150
Lamivudine
- Imprint
- APO LMV 150
- Strength
- 150 mg
- Color
- White
- Size
- 14.00 mm
- Shape
- Four-sided
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Inc.
- Inactive Ingredients
-
lactose anhydrous,
crospovidone,
silicon dioxide,
hypromelloses,
hydroxypropyl cellulose,
magnesium stearate,
polyethylene glycol,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00904-6583 | Major Pharmaceuticals |
| 60505-3251 | Apotex Corp. |
See also:
More about lamivudine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.